FSHB rs11031004: Understanding Its Role in Reproduction
The rs11031004 variant is a non-coding single nucleotide polymorphism located near the FSHB gene on chromosome 11. It is involved in regulating levels of follicle-stimulating hormone, a key driver of ovarian follicle development and sperm maturation. Population studies link this variant to subtle differences in reproductive parameters, including the likelihood of dizygotic twinning and menstrual cycle patterns.
What each genotype means
Typical FSH expression and ovulation
You carry two copies of the common C allele near the FSHB gene, which is associated with baseline circulating levels of follicle-stimulating hormone. Population studies indicate typical rates of multiple ovulation and standard timing of reproductive milestones. This variant does not guarantee any specific fertility outcome, as reproductive traits are influenced by many hormonal and environmental factors.
Carried by approximately 70% of individuals of European ancestry, with higher frequencies reported in East Asian populations.
Modestly higher twinning likelihood
You have one copy of the T allele near the FSHB gene, which has been linked in genome-wide association studies to slightly altered circulating follicle-stimulating hormone levels. In large European cohorts, this allele is weakly associated with an increased likelihood of spontaneous dizygotic twinning and slight shifts in menstrual cycle characteristics. These findings represent small population-level statistical differences and do not constitute a diagnosis or a prediction for any individual pregnancy.
Carried by approximately 25% to 28% of individuals of European ancestry; it occurs at substantially lower frequencies in East Asian and African ancestries.
Elevated spontaneous twinning association
Carrying two copies of the T allele has been linked to the strongest relative effect on regulatory expression of follicle-stimulating hormone among the common genotypes at this locus. Research in female cohorts identifies a statistically higher rate of spontaneous dizygotic twinning and potential variations in cycle regulation compared to non-carriers. Evidence remains limited and largely restricted to European populations, meaning overall reproductive outcomes continue to be shaped by a broad range of biological and clinical factors.
Carried by approximately 2% to 3% of individuals of European ancestry, and is rare in most other global populations.
Genomic Context and the FSHB Locus
The single nucleotide polymorphism rs11031004 is situated on chromosome 11 near the follicle-stimulating hormone subunit beta (FSHB) gene. Rather than altering an amino acid sequence in the protein itself, this polymorphism resides in a regulatory region flanking the gene. Regulatory variations in this locus can influence how efficiently the FSHB gene is transcribed into messenger RNA, thereby modulating the quantity of hormone synthesized and secreted by the anterior pituitary gland. Because rs11031004 is located in a broader non-coding genomic landscape, it often exists in linkage disequilibrium with other nearby genetic markers across the FSHB locus. This means that observed biological traits may stem from rs11031004 directly or from a group of co-inherited variants operating together. Scientists use tools like genome browsers to map these non-coding regions and assess how upstream and downstream variations alter binding sites for transcription factors that control reproductive signaling cascades.
Biological Role of Follicle-Stimulating Hormone
The FSHB gene encodes the beta subunit of follicle-stimulating hormone (FSH), a heterodimeric glycoprotein that works alongside luteinizing hormone to orchestrate mammalian reproduction. In females, circulating FSH binds to its receptor on ovarian granulosa cells, stimulating the recruitment, maturation, and estrogen production of ovarian follicles throughout the follicular phase of the menstrual cycle. Proper regulation of FSH levels dictates whether a single dominant follicle matures during a typical monthly cycle or whether multiple follicles reach the ovulatory stage. In males, FSH acts on testicular Sertoli cells to support normal spermatogenesis and maintain reproductive endocrine balance. Because the beta subunit provides FSH with its unique biological specificity, subtle alterations in the transcription of FSHB can influence systemic circulating hormone levels. Even slight shifts in baseline hormone availability can alter physiological milestones, such as timing of menarche, natural cycle duration, and follicle recruitment dynamics.
Associations with Twinning and Reproductive Physiology
Large-scale genome-wide association studies have identified variants in the FSHB region, including the rs11031004 locus, as significant markers associated with the likelihood of having spontaneous dizygotic (fraternal) twins. Fraternal twinning requires multiple ovulation, a maternal physiological trait heavily dependent on sustained gonadotropin support. Research published through international twinning consortia demonstrated that alleles linked to higher pituitary output of FSH increase the statistical probability that more than one egg is released during a single cycle. Beyond fraternal twinning, studies have investigated correlations between FSHB variation and menstrual cycle irregularity, age at natural menarche, and conditions like polycystic ovary syndrome. However, the evidence strength for rs11031004 remains characterized as limited to moderate. While population-level statistical associations are detectable in large cohorts, the absolute effect size on an individual's personal fertility profile or cycle regularity is modest, and it cannot reliably predict clinical reproductive outcomes on its own.
Ancestry and Population Distribution
The distribution of alleles at the rs11031004 locus varies markedly across global populations. In individuals of European ancestry, the minor allele frequency is approximately 0.16, meaning roughly 16% of chromosomes carry the variant allele. Conversely, allele frequencies differ considerably in African, East Asian, and South Asian ancestral cohorts cataloged in public genomic reference databases such as gnomAD and 1000 Genomes. Population geneticists have noted that the broader FSHB genomic region displays patterns consistent with evolutionary balancing selection, where multiple ancestral haplotypes have been preserved across human lineages due to their direct impact on reproductive fitness and survival. Because genetic architecture and linkage disequilibrium patterns differ between ancestral backgrounds, association findings identified predominantly in European cohorts may not confer the identical statistical effect size or biological relevance in non-European ancestries, highlighting the critical need for multi-ancestry reproductive genomic research.
Interpreting Genetic Results in Clinical Context
Understanding one's genotype at rs11031004 provides an educational look into the complex endocrine genetics governing human reproduction, but it is not a diagnostic test. Carrying an allele statistically associated with higher FSH levels or dizygotic twinning does not guarantee that a person will conceive twins, experience irregular periods, or encounter fertility difficulties. Human fertility and menstrual health are multifactorial, shaped by numerous environmental, metabolic, lifestyle, and polygenic factors that far outweigh the contribution of any single non-coding SNP. Genotypic information from direct-to-consumer testing cannot replace routine gynecological or endocrinological care, hormonal blood panels, or ovarian reserve evaluations. Individuals with concerns regarding menstrual irregularity, ovulatory dysfunction, or family planning should consult an obstetrician-gynecologist or reproductive endocrinologist rather than relying on exploratory genetic variant data to guide medical decisions.
How common is this variant?
The minor allele at rs11031004 has an estimated frequency of approximately 0.16 in European populations, with frequencies varying substantially across other ancestral groups in global genomic reference databases.
Frequently asked questions
Does having the rs11031004 variant mean I will definitely have twins?
No. Genetic variants identified in GWAS studies only shift statistical odds within large populations. While rs11031004 is linked to a slightly increased likelihood of releasing multiple eggs in a cycle, spontaneous fraternal twinning remains relatively uncommon and is influenced by maternal age, family history, and nutrition.
Can this genetic variant cause female infertility?
There is no evidence that rs11031004 independently causes infertility. The variant exhibits limited associations with slight variations in menstrual cycle length and hormone output, but common forms of infertility typically involve distinct underlying medical or structural conditions.
Is rs11031004 used in medical or fertility clinic testing?
No, reproductive clinics do not routinely test for rs11031004. Standard clinical assessments rely on measured serum hormone concentrations (such as FSH, LH, and AMH) and ultrasound imaging, which provide direct and actionable measurements of reproductive function.
Does rs11031004 affect men?
Although the FSHB gene is essential for male sperm production, most published research on rs11031004 focuses on female reproductive traits such as twinning and menstrual cycles. Regulatory changes in FSHB can theoretically influence male hormone dynamics, but direct clinical effects of this specific SNP in males remain understudied.
Sources & further reading
Educational information only, last refreshed 9/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11031004?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FSHB
Promoter-adjacent variant linked to FSHB expression, influencing basal follicle-stimulating hormone levels, menstrual cycle duration, and twinning propensity.
Pathogenic loss-of-function variant causing isolated follicle-stimulating hormone deficiency leading to hypogonadotropic hypogonadism.
Functional promoter variant in FSHB influencing serum FSH concentrations and reproductive lifespan.
Variant in the promoter region of FSHB associated with circulating follicle-stimulating hormone levels, age at menarche, and reproductive lifespan.
Located in the promoter of FSHB (c.-211G>T), this variant downregulates follicle-stimulating hormone transcription and is strongly associated with male infertility traits (oligozoospermia) and altered female reproductive lifespan.
Variant in the promoter region of FSHB associated with altered follicle-stimulating hormone levels, timing of menarche, and female reproductive lifespan.